Contractor directory
UEI W452WY5E2JQ9 · CAGE 7JTR0

Ophirex, Inc

Ophirex, Inc received $0 in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 100.0% from −$645K the year before, and $24.4M since FY2022. Its largest customer is the Department of Defense.

Obligations, latest 12 months
$0
up 100.0% vs. −$645K
Since FY2022
$24.4M
4 awards
Awards with activity
0
Latest 12 months
Most recent action
Sep 5, 2025
First seen Jan 10, 2022

Contractor details

Unique Entity ID (UEI)
W452WY5E2JQ9
CAGE code
7JTR0
Headquarters
Corte Madera, CA
Business size
Small Business

As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.

Obligations by fiscal year

Net prime contract obligations by federal fiscal year.

FY2022
$14.0M
FY2023
$6.5M
FY2024
$4.5M
FY2025
−$645K

Top agencies

Funding agencies ranked by obligations since FY2022.

Funding agencyLatest 12 moSince FY2022
Department of Defense$0$24.4M

Top NAICS codes

Industry codes agencies recorded on this contractor's awards, since FY2022.

NAICSIndustryLatest 12 moSince FY2022
541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)$0$24.4M

What it sells

Product and service codes (PSC) on this contractor's awards, since FY2022.

PSCDescriptionSince FY2022
AN13Health R&D services; Health Care services; Experimental Development$23.4M
AN12Health R&D services; Health Care services; Applied Research$1.3M

Recent awards

This contractor's newest prime contract awards, most recent first.

AwardAgencyObligatedAwarded
HT942523C0061
Department of Defense
DHA PH II SEQL PROPOSAL H2S-0045, TITLE: BROAD-SPECTRUM SNAKEBITE ANTIDOTE: METALLOPROTEASE INHIBITION TO IMPROVE RECOVERY TIME FOLLOWING SNAKEBITE, MEDICAL R & D EGS 23000510
$1.3MAug 22, 2023
W81XWH22C0030
Department of Defense
FOLLOW ON PHASE III RESEARCH AND DEVELOPMENT SBIR FOR PROJECT TITLED, BROAD-SPECTRUM SNAKEBITE ANTIDOTE: ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY
$13.8MApr 5, 2022

Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.

Ready to win more?

Ready to connect your pursuit work?

GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.